Back to LAZARD ASSET MANAGEMENT LLC LAZARD ASSET MANAGEMENT LLC

XERSXERS

Showing 0 of 6 quarters

Position history for LAZARD ASSET MANAGEMENT LLCLAZARD ASSET MANAGEMENT LLC's holdings in XERIS PHARMACEUTICALS INC

As of its Q3 2021 13F, Lazard Asset Management held 150,107 shares of XERS (Xeris Pharmaceuticals), worth $367,000. Lazard Asset Management's 13F filings listed XERS from Q3 2020 to Q3 2021, 5 quarterly filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used